This year a great deal of research done at EPFL made the headlines in newspapers. Here are a few that marked the months of May to August. May 5 - 33 million to rehabilitate white blood cells - Multiple sclerosis, type 1 diabetes. When the immune system gets out of control consequences can be dramatic. The Anokion start-up will ensure the development of EPFL's research aiming to rehabilitate rogue white blood cells. Private investors have injected CHF 33 million to this new company. May 12 - The incredibly fast robotic arm - Robots' movements often seem slow and clumsy.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
Your Benefits
- Access to all content
- Receive newsmails for news and jobs
- Post ads
